Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Intracellular delivery of a phospholamban-targeting aptamer using cardiomyocyte-internalizing aptamers.

European journal of pharmacology·2024
Same author

Postnatal Pdzrn3 deficiency causes acute muscle atrophy without alterations in endplate morphology.

Biochemical and biophysical research communications·2024
Same author

Local immune checkpoint blockade therapy by an adenovirus encoding a novel PD-L1 inhibitory peptide inhibits the growth of colon carcinoma in immunocompetent mice.

Translational oncology·2022
Same author

Calcium/calmodulin-dependent regulation of Rac GTPases and Akt in histamine-induced chemotaxis of mast cells.

Cellular signalling·2021
Same author

PDZRN3 protects against apoptosis in myoblasts by maintaining cyclin A2 expression.

Scientific reports·2020
Same author

Generation of Specific Aptamers.

Methods in molecular biology (Clifton, N.J.)·2018

相关实验视频

Updated: Jul 5, 2025

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.4K

产生特定的aptamers的生成.

Shuang Liu1, Yasuyuki Suzuki2, Makoto Inui3

  • 1Department of Pharmacology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan. liussmzk@m.ehime-u.ac.jp.

Methods in molecular biology (Clifton, N.J.)
|January 25, 2024
PubMed
概括

核酸体是作为治疗剂使用的短DNA或RNA分子. 蛋白质体-SELEX方法有效地产生这些体,以高亲和度与标结合,在药物开发中比抗体具有优势.

关键词:
亚普特美尔 (Aptamer) 是一种药物.这是一个PCRPCR.蛋白质体蛋白质体这就是SELEXEX.单链DNA是一种单链DNA.

更多相关视频

Primer-Free Aptamer Selection Using A Random DNA Library
11:14

Primer-Free Aptamer Selection Using A Random DNA Library

Published on: July 26, 2010

24.8K
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.2K

相关实验视频

Last Updated: Jul 5, 2025

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.4K
Primer-Free Aptamer Selection Using A Random DNA Library
11:14

Primer-Free Aptamer Selection Using A Random DNA Library

Published on: July 26, 2010

24.8K
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.2K

科学领域:

  • 生物技术是生物技术.
  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 核酸体是单链DNA或RNA寡核酸.
  • 阿普塔默对治疗点具有很高的亲和力和特异性.
  • 它们比抗体具有优势,包括易于合成和修饰.

研究的目的:

  • 通过指数式丰富 (SELEX) 技术引入连接体的蛋白质体系统演化.
  • 用这种方法来证明潜在的治疗剂的产生.

主要方法:

  • 使用DNA-寡核酸池.使用DNA-寡核酸池.
  • 采用蛋白质体-SELEX技术进行连接体选择.

主要成果:

  • 蛋白质体-SELEX方法产生具有高亲和度和特异性的体.
  • 这项技术使得开发强效治疗剂成为可能.

结论:

  • 蛋白质基体-SELEX是一种有效的技术,用于发现基于aptamer的治疗方法.
  • 阿普塔默是一种有前途的药物类别,特别是在诸如类风湿性关节炎等疾病中.